Debt to EBITDA ratio Analysis of BioLineRx Ltd - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of BLRX
Dec-23-0.217Very Poor Debt to EBITDA | Dec-22-0.371Very Poor Debt to EBITDA | Growth41.53% |
Debt to EBITDA Analysis of BioLineRx Ltd
| Debt to EBITDA Ratio of BLRX rose handsomely by 41.53 % this year. |
| Debt to EBITDA Ratio with value of -0.115 was highest in Year Dec-21 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.383 was lowest in Year Dec-19 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.217 is Greater than Average Debt to EBITDA of -0.261 in last five years. |
Other Debt to EBITDA Related Info of BLRX that may interest you.
BioLineRx Ltd Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BLRX | 0.7456 | 0.8198 | 9.05 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Poor Stability Stock | |
FY - Historical Debt to EBITDA of BioLineRx Ltd
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.217 | -0.371 | -0.115 | -0.218 | -0.383 | -0.390 | -0.0105 |
| Change | 41.53 % | -221.39 % | 47.13 % | 43.11 % | 1.69 % | -3619.99 % | 53.11 % |
FY Chart of Debt to EBITDA of BioLineRx Ltd
Note : All Data Generated at the End of Trading Hours (EOD Data)